Erste Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,559,587
| Closed | -$2.89M | – | 969 |
|
|
2023
Q1 | $2.89M | Buy |
1,559,587
+100,000
| +7% | +$185K | 0.06% | 258 |
|
|
2022
Q4 | $1.62M | Buy |
1,459,587
+610,000
| +72% | +$677K | 0.03% | 298 |
|
|
2022
Q3 | $1.98M | Hold |
849,587
| – | – | 0.04% | 282 |
|
|
2022
Q2 | $2.57M | Buy |
849,587
+80,000
| +10% | +$242K | 0.06% | 264 |
|
|
2022
Q1 | $5.23M | Buy |
769,587
+40,000
| +5% | +$272K | 0.1% | 213 |
|
|
2021
Q4 | $5.92M | Sell |
729,587
-50,000
| -6% | -$406K | 0.11% | 193 |
|
|
2021
Q3 | $5.79M | Buy |
779,587
+120,000
| +18% | +$891K | 0.11% | 181 |
|
|
2021
Q2 | $4.47M | Buy |
659,587
+25,000
| +4% | +$170K | 0.09% | 215 |
|
|
2021
Q1 | $6.49M | Buy |
634,587
+50,000
| +9% | +$512K | 0.16% | 160 |
|
|
2020
Q4 | $3.9M | Hold |
584,587
| – | – | 0.11% | 191 |
|
|
2020
Q3 | $4.77M | Buy |
584,587
+30,000
| +5% | +$245K | 0.16% | 150 |
|
|
2020
Q2 | $3.83M | Sell |
554,587
-50,000
| -8% | -$345K | 0.15% | 151 |
|
|
2020
Q1 | $2.87M | Sell |
604,587
-68,100
| -10% | -$323K | 0.17% | 150 |
|
|
2019
Q4 | $5.47M | Buy |
672,687
+40,000
| +6% | +$325K | 0.24% | 105 |
|
|
2019
Q3 | $2.11M | Buy |
632,687
+25,000
| +4% | +$83.4K | 0.11% | 180 |
|
|
2019
Q2 | $3M | Buy |
607,687
+39,000
| +7% | +$192K | 0.16% | 137 |
|
|
2019
Q1 | $3.52M | Buy |
568,687
+258,587
| +83% | +$1.6M | 0.2% | 125 |
|
|
2018
Q4 | $1.04M | Buy |
+310,100
| New | +$1.04M | 0.07% | 232 |
|